Protective effects of the GLP-1 mimetic exendin-4 in Parkinson's disease
Suicidality concerns: what we know now Regulatory reviews by the FDA and EMA have not found evidence that GLP-1s cause suicidal thoughts or behaviors, though monitoring continues (FDA, 2024
When using research peptides, you take on responsibility for proper reconstitution, dosing calculations, and sterile injection technique
How to get tirzepatide out of your system is a common question for patients discontinuing Mounjaro or Zepbound
A meta-analysis of 5 RCTs 42,43,44,45,46 comprising 7,732 adults with T2DM did not observe any effect on cognition, as measured via mini-mental state examination (MMSE) or Montreal cognitive assessment (MoCA), of GLP-1RAs over several months compared with the baseline 38